Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Nucleic Acids Research
|
November 7, 2006
Role of metal ions in catalysis by HIV integrase analyzed using a quantitative PCR disintegration assay
Tracy L Diamond, Frederic D Bushman
Journal of Virology
|
November 25, 2005
Division of labor within human immunodeficiency virus integrase complexes: determinants of catalysis and target DNA capture
Tracy L Diamond, Frederic D Bushman
Biochemistry
|
May 5, 2009
Mechanistic variations among reverse transcriptases of simian immunodeficiency virus variants isolated from African green monkeys
Mark Skasko, Tracy L Diamond, Baek Kim
Human Gene Therapy
|
September 16, 2006
Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor
Angela Ciuffi, Tracy L Diamond, Young Hwang, et al.
The Journal of Biological Chemistry
|
May 13, 2003
Mechanistic understanding of an altered fidelity simian immunodeficiency virus reverse transcriptase mutation, V148I, identified in a pig-tailed macaque
Tracy L Diamond, George Souroullas, Kellie K Weiss, et al.
The Journal of Infectious Diseases
|
June 10, 2024
Cytomegalovirus Antiviral Resistance Among Kidney Transplant Recipients in a Phase 3 Trial of Letermovir vs Valganciclovir Prophylaxis
Julie M Strizki, Tracy L Diamond, Valerie L Teal, et al.
Antimicrobial Agents and Chemotherapy
|
June 12, 2024
No antagonism or cross-resistance and a high barrier to the emergence of resistance <i>in vitro</i> for the combination of islatravir and lenacapavir
Tracy L Diamond, Shih Lin Goh, Winnie Ngo, et al.
Antimicrobial Agents and Chemotherapy
|
May 12, 2022
Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Tracy L Diamond, Winnie Ngo, Min Xu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 26, 2026
Resistance Analysis of Weekly Islatravir Plus Lenacapavir in People with HIV at 48 Weeks
Laurie A VanderVeen, Lisa Selzer, Silvia Chang, et al.
Antimicrobial Agents and Chemotherapy
|
May 2, 2022
Doravirine and Islatravir Have Complementary Resistance Profiles and Create a Combination with a High Barrier to Resistance
Ming-Tain Lai, Meizhen Feng, Min Xu, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Nucleic Acids Research
|
November 7, 2006
Role of metal ions in catalysis by HIV integrase analyzed using a quantitative PCR disintegration assay
Tracy L Diamond, Frederic D Bushman
Journal of Virology
|
November 25, 2005
Division of labor within human immunodeficiency virus integrase complexes: determinants of catalysis and target DNA capture
Tracy L Diamond, Frederic D Bushman
Biochemistry
|
May 5, 2009
Mechanistic variations among reverse transcriptases of simian immunodeficiency virus variants isolated from African green monkeys
Mark Skasko, Tracy L Diamond, Baek Kim
Human Gene Therapy
|
September 16, 2006
Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor
Angela Ciuffi, Tracy L Diamond, Young Hwang, et al.
The Journal of Biological Chemistry
|
May 13, 2003
Mechanistic understanding of an altered fidelity simian immunodeficiency virus reverse transcriptase mutation, V148I, identified in a pig-tailed macaque
Tracy L Diamond, George Souroullas, Kellie K Weiss, et al.
The Journal of Infectious Diseases
|
June 10, 2024
Cytomegalovirus Antiviral Resistance Among Kidney Transplant Recipients in a Phase 3 Trial of Letermovir vs Valganciclovir Prophylaxis
Julie M Strizki, Tracy L Diamond, Valerie L Teal, et al.
Antimicrobial Agents and Chemotherapy
|
June 12, 2024
No antagonism or cross-resistance and a high barrier to the emergence of resistance <i>in vitro</i> for the combination of islatravir and lenacapavir
Tracy L Diamond, Shih Lin Goh, Winnie Ngo, et al.
Antimicrobial Agents and Chemotherapy
|
May 12, 2022
Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Tracy L Diamond, Winnie Ngo, Min Xu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 26, 2026
Resistance Analysis of Weekly Islatravir Plus Lenacapavir in People with HIV at 48 Weeks
Laurie A VanderVeen, Lisa Selzer, Silvia Chang, et al.
Antimicrobial Agents and Chemotherapy
|
May 2, 2022
Doravirine and Islatravir Have Complementary Resistance Profiles and Create a Combination with a High Barrier to Resistance
Ming-Tain Lai, Meizhen Feng, Min Xu, et al.
Page
of 3